Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-16-070634

Senior Vice President and CFO sold 3,250 shares at $7.45 ($24,213)

  • Senior Vice President and CFO acquired 3,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-12-19 Exercise or conversion : show line 1 in the form +3,250 $3.78 $12,285 127,437 D
2016-12-19 Sale : show line 2 in the form −3,250 $7.45 $24,213 124,187 D
Open-market sales · 3,250 sh · avg $7.45 · $24,213

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-19 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −3,250 $3.78 2021-07-01 3,250 96,010 D
Loading xslF345X03/form4.xml…